BPG is committed to discovery and dissemination of knowledge
Review
Copyright: ©Author(s) 2026.
World J Diabetes. Mar 15, 2026; 17(3): 112177
Published online Mar 15, 2026. doi: 10.4239/wjd.v17.i3.112177
Figure 2
Figure 2 Autoimmune destruction of pancreatic β cells in type 1 diabetes. The diagram illustrates the pathophysiology of type 1 diabetes mellitus, showing the progressive autoimmune attack on insulin-producing β cells within the pancreatic islets of Langerhans (left panel). The normal pancreatic islet architecture contains α cells (producing glucagon), β cells (producing insulin), and δ cells (producing somatostatin) (middle panel). In type 1 diabetes, autoreactive cytotoxic T cells recognize β cell-specific antigens and mount an immune attack against insulin-producing cells, whereas α and δ cells remain largely unaffected (right panel). The end result of this autoimmune process is the selective destruction of β cells, leading to complete insulin deficiency, whereas glucagon and somatostatin production from α and δ cells continues. This autoimmune-mediated β-cell destruction results in the characteristic hyperglycemia and insulin dependence observed in type 1 diabetes patients. This figure was created by BioRender.com (Supplementary material).


Write to the Help Desk